These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7647820

  • 41. Effects of an ad libitum low-fat, high-carbohydrate diet on body weight, body composition, and fat distribution in older men and women: a randomized controlled trial.
    Hays NP, Starling RD, Liu X, Sullivan DH, Trappe TA, Fluckey JD, Evans WJ.
    Arch Intern Med; 2004 Jan 26; 164(2):210-7. PubMed ID: 14744846
    [Abstract] [Full Text] [Related]

  • 42. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R, Faulds D.
    Drugs; 1996 Nov 26; 52(5):696-724. PubMed ID: 9118819
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparison of high-fat and high-carbohydrate foods in a meal or snack on short-term fat and energy intakes in obese women.
    Green SM, Wales JK, Lawton CL, Blundell JE.
    Br J Nutr; 2000 Oct 26; 84(4):521-30. PubMed ID: 11103223
    [Abstract] [Full Text] [Related]

  • 45. Dexfenfluramine hydrochloride: an anorexigenic agent.
    Bever KA, Perry PJ.
    Am J Health Syst Pharm; 1997 Sep 15; 54(18):2059-72. PubMed ID: 9377205
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference.
    Smith BK, York DA, Bray GA.
    Pharmacol Biochem Behav; 1998 May 15; 60(1):105-14. PubMed ID: 9610931
    [Abstract] [Full Text] [Related]

  • 51. Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine.
    Boschmann M, Aust L, Frenz U, Noack R.
    Ann Nutr Metab; 1996 May 15; 40(1):10-23. PubMed ID: 8722302
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Snacking frequency in relation to energy intake and food choices in obese men and women compared to a reference population.
    Bertéus Forslund H, Torgerson JS, Sjöström L, Lindroos AK.
    Int J Obes (Lond); 2005 Jun 15; 29(6):711-9. PubMed ID: 15809664
    [Abstract] [Full Text] [Related]

  • 54. Lower fat intake as a predictor of initial and sustained weight loss in obese subjects consuming an otherwise ad libitum diet.
    Carmichael HE, Swinburn BA, Wilson MR.
    J Am Diet Assoc; 1998 Jan 15; 98(1):35-9. PubMed ID: 9434648
    [Abstract] [Full Text] [Related]

  • 55. Body weight evolution during dexfenfluramine treatment after initial weight control.
    Finer N.
    Int J Obes Relat Metab Disord; 1992 Dec 15; 16 Suppl 3():S25-9. PubMed ID: 1338319
    [Abstract] [Full Text] [Related]

  • 56. Should snacks be recommended in obesity treatment? A 1-year randomized clinical trial.
    Bertéus Forslund H, Klingström S, Hagberg H, Löndahl M, Torgerson JS, Lindroos AK.
    Eur J Clin Nutr; 2008 Nov 15; 62(11):1308-17. PubMed ID: 17700649
    [Abstract] [Full Text] [Related]

  • 57. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation.
    Spring B, Wurtman J, Wurtman R, el-Khoury A, Goldberg H, McDermott J, Pingitore R.
    Am J Clin Nutr; 1995 Dec 15; 62(6):1181-7. PubMed ID: 7491877
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.